Product Details
Product Sizes
| Size | List Price | Price | Cart |
|---|---|---|---|
| 1.5 mls | $410.00 | Add to Cart |
n-FectTM is a cationic lipid that has been emperically formulated for nervous system applications. n-Fect has a lower tocicity profile for primary neural cells than most cationic lipids. Cell lines (see figure): n-Fect has worked well on neural and glial cells with a high transfection efficency. Primary Neurons: Like most cationic lipids, the transfection effecency for most of our customers in primary neurons has been fairly low. The main observed advantage of n-Fect compared with other cationic lipid products is its low toxicity. At the recommended transfection ratios, neurons remain healthy. The observed transfection efficency in primary neurons has been approximately 10% - but has been variable from lab to lab. We therefore offer this kit in a trial size to test in your unique cell culture conditions. n-Fect has been use for plasmid transfection in Experimental Crescentic Glomerulonephritis. See n-Fect: Publications Kit Contents
NF30150: 1.5 mls -75-300 Transfections NF30750: 5 x 1.5 mls - 375-1500 Transfections |
- Product Reviews
Leave a review for this product and you could be eligible for a $10 Starbucks gift card.
- Product Publications
Product Publications
- Larry Rodriguez. (2020). Mechanisms of P2XR-Mediated Ethanol Consumption. University of Southern California, Doctoral Dissertation
- Amy N. Sussman, Tong Sun, Ronald M. Krofft, and Raghu V. Durvasula. (2009). Accelerates Disease Progression in Experimental Crescentic Glomerulonephritis. Am. J. Pathol, 174: 1827 - 1836; doi: 10.2353/ajpath.2009.080464
- Hidetaka Sadanari, Junji Tanaka, Zhuan Li, Rie Yamada, Keiko Matsubara and Tsugiya Murayama. (2009). Proteasome inhibitor differentially regulates expression of the major immediate early genes of human cytomegalovirus in human central nervous system-derived cell lines. Virus Research, doi: 10.1016/j.virusres.2009.01.010.
- King-Ho Cheung, Diana Shineman, Marioly Müller, César Cárdenas, Lijuan Mei1, Jun Yang, Taisuke Tomita, Takeshi Iwatsubo, Virginia M.-Y. Lee, and J. Kevin Foskett. (2008). Mechanism of Ca2+ Disruption in Alzheimer's Disease by Presenilin Regulation of InsP3 Receptor Channel Gating. Neuron, doi: 10.1016/j.neuron.2008.04.015
- Griffin SV, Hiromura K, Pippin J, Petermann AT, Blonski MJ, Krofft R, Takahashi S, Kulkarni AB, Shankland SJ. (2004). Cyclin-Dependent Kinase 5 Is a Regulator of Podocyte Differentiation, Proliferation, and Morphology. Am J Pathol. 165:1175-1185; doi: 10.1016/S0002-9440(10)63378-0
If you've used this product in a publication, let us know. Email rose@neuromics.com, with the publication details and you could be eligible for an Amazon gift card.
- Related Products
Related Products
Name Catalog # Size DNA-Fect DF37100-1 1 ml DNA-Fect293 DF37293-1 1 ml i-Fect NI35150 1 x 0.75 ml i-Fect NI35750 5 x 0.75 ml n-Blast NB30075 0.75 ml n-Blast NB30150 1.5 ml n-Fect NF30750 5 x 1.5 mls p-Fect PF30000 5x8 mls-DNA Diluent p-Fect PF30001 10x8 mls-DNA Diluent p-Fect PF30002 5x8 mls-DNA Diluent B p-Fect PF30003 10x8 mls-DNA Diluent B p-Fect PF30075 75 Reactions p-Fect PF30150 150 Reactions p-Fect PF30750 750 Reactions Penetratin 1 CP51101 500 ugs pro-Fect PT30000 24 Reactions pro-Fect PT30002 96 Reactions siRNA-intact SI35100 100 units in 100 ul